跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
MIF-1
首页
药物
MIF-1
MIF-1
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
US 7105519 B2
申请人: AVANIR PHARMACEUTICALS
优先权: 2001
CN
US
26 件公开
US 7173036 B2
申请人: AVANIR PHARMACEUTICALS
优先权: 2004
US
11 件公开
THERAPEUTIC AGENT FOR DISEASE BASED ON INHIBITORY EFFECT OF MACROPHAGE MIGRATION INHIBITORY FACTOR
EP 2929880 B1
申请人: TOYAMA CHEMICAL CO LTD
优先权: 2013
CN
EP
US
WO
6 件公开
METHODS OF TREATING COGNITIVE IMPAIRMENT
US 2011142795 A1
申请人: UNIV SOUTH FLORIDA
优先权: 2009
CN
US
5 件公开
US 9132168 B2
申请人: POTTER HUNTINGTON
优先权: 2011
US
4 件公开
1, 3-benzothiazinone derivatives and use thereof
US 7399759 B2
申请人: TAKEDA PHARMACEUTICAL
优先权: 2001
US
4 件公开
MACROPHAGE MIGRATION INHIBITORY FACTOR (MIF) TARGETING FOR THE TREATMENT OF NON-SMALL CELL LUNG CANCER
EP 4615582 A1
申请人: UNIV TEXAS
优先权: 2022
EP
US
WO
3 件公开
Substituted naphthyridine derivatives as inhibitors of macrophage migration inhibitory factor and their use in the treatment of human diseases
US 2005124604 A1
申请人: SIRCAR JAGADISH
优先权: 2004
US
3 件公开
Screening method, a composition comprising substances chosen in the method thereof, and a binding substance
US 2009170108 A1
申请人: YODOI JUNJI
优先权: 2006
US
3 件公开
1,3-BENZOTHIAZINONE DERIVATIVE AND USE THEREOF
US 2009029975 A1
申请人: TAKEDA PHARMACEUTICAL
优先权: 2005
EP
US
2 件公开
MIF INHIBITORS AND METHODS OF USE THEREOF
US 2022249597 A1
申请人: UNIV JOHNS HOPKINS
优先权: 2016
CN
US
2 件公开
Differential tumor cytotoxicity compounds and compositions
US 7125997 B2
申请人: IRM LLC
优先权: 2003
US
2 件公开
第 1 / 3 页
上一页
下一页
药物
反馈